Recent News

The American Physical Society (APS) has awarded Dr. Luis De Jesús Báez the 2024 FECS Diversity & Inclusion Award for his work to support and create opportunities for students from underrepresented backgrounds. This award represents efforts by Dr. De Jesús Báez from his postdoctoral and independent career, such as initiating a program connecting students from the University of Puerto Rico Cayey to REU and graduate opportunities at Texas A&M University.

A study published two years ago by Prof. David Heppner reported the first three-dimensional structures of Lazcluze (Lazertinib). The FDA recently approved this drug administered in combination with Rybrevant (Amivantamab) for the treatment of lung cancer.

The Analytical Scientist has included Prof. Aga in their 2024 impact list as a recognition of the Aga group’s impactful work at the forefront of planet protecting research, such emerging contaminants like PFAS. Read more in this article in The Analytical Scientist.

 

Prof. David Heppner has been awarded an NIGMS MIRA grant from the NIH to pursue research studies to alleviate the guesswork from the drug discovery process, thereby reducing costs and the time to new medicines. University at Buffalo News Release.